IQI
BVS icon

Integrated Quantitative Investments’s Bioventus BVS Stock Holding History

Integrated Quantitative Investments’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+31,816
New +$304K 0.05% 329
2025
Q2 		– Sell
-24,888
Closed -$228K – 377
2025
Q1 		$228K Sell
24,888
-37
-0.1% -$370 0.11% 252
2024
Q4 		$262K Buy
+24,925
New +$295K 0.13% 258

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Integrated Quantitative Investments's BVS Position: Q2 2026 in Review

Integrated Quantitative Investments opened a new position in Bioventus (BVS) in Q2 2026: 31,816 shares worth $300K. The stake represents 0.05% of the portfolio and ranks #329 among its holdings. This is a return to the name: Integrated Quantitative Investments previously reported a position in BVS as recently as Q1 2025.

Integrated Quantitative Investments first reported a position in BVS in Q4 2024 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Integrated Quantitative Investments held 31,816 shares of Bioventus worth $300K as of Q2 2026.
  • Bioventus was a new Integrated Quantitative Investments position in Q2 2026.
  • Bioventus made up 0.05% of Integrated Quantitative Investments's portfolio in Q2 2026, its #329 holding.
  • Integrated Quantitative Investments first reported a position in Bioventus in Q4 2024 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.